eversyn is a startup based in Germany. Brouky records 1 investor associated with the company.
Eversyn develops and supplies premium-grade glycan building blocks and enzymes for research and industrial applications, enabling scalable production of complex glycans for nutrition and biopharmaceuticals.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.